Equifax, Incorporated
EFXNYSECIK 33185Industrials / Business Servicesfiscal year ends December71 quarters since 2009
Latest quarter Q3 FY2026, filed October 20, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of October 20, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed October 20, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 20, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 21, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 21, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 21, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 22, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 22, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,693 | 1,700 | 1,649 | 1,551 | 1,545 | 1,537 | 1,442 | 1,419 | +9.6% |
| Cost of revenue | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 390 | 423 | 411 | 421 | 434 | 384 | 375 | 345 | −10.1% |
| Operating income | 355 | 314 | 288 | 284 | 264 | 311 | 236 | 288 | +34.4% |
| Other income (expense) | 4 | 3 | 4 | 3 | 3 | 4 | 3 | (7) | +18.8% |
| Pretax income | 297 | 257 | 236 | 233 | 215 | 261 | 185 | 226 | +37.9% |
| Income tax | 83 | 72 | 63 | 57 | 54 | 69 | 52 | 52 | +55.0% |
| Net income | 212 | 184 | 172 | 176 | 160 | 191 | 133 | 174 | +32.1% |
| Diluted EPS ($) | 1.79 | 1.54 | 1.42 | — | 1.29 | 1.53 | 1.06 | — | +38.8% |
| Diluted shares (millions) | 118 | 119 | 121 | — | 124 | 125 | 125 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed October 20, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 20, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 21, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 21, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 21, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 22, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 22, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 193 | 170 | 183 | 181 | 189 | 189 | 195 | 170 | +2.1% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | 1,587 | 1,581 | 1,487 | 1,412 | 1,463 | 1,502 | 1,476 | 1,361 | +8.4% |
| Total assets | 11,937 | 11,982 | 11,942 | 11,864 | 11,832 | 11,918 | 11,855 | 11,759 | +0.9% |
| Total current liabilities | 1,460 | 2,626 | 2,451 | 2,335 | 1,984 | 1,946 | 1,731 | 1,812 | −26.4% |
| Long-term debt | 5,049 | 4,057 | 4,056 | 4,055 | 4,054 | 4,051 | 4,324 | 4,323 | +24.5% |
| Total liabilities | 7,323 | 7,462 | 7,259 | 7,126 | 6,756 | 6,682 | 6,742 | 6,840 | +8.4% |
| Stockholders’ equity | 4,473 | 4,380 | 4,541 | 4,604 | 4,939 | 5,104 | 4,981 | 4,797 | −9.4% |
| Shares outstanding (millions) | 117 | 117 | 119 | 120 | 122 | 124 | 124 | 124 | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed October 20, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 20, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 21, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 21, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 21, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 22, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 22, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 560 | 340 | 242 | 471 | 560 | 361 | 224 | 325 | +0.1% |
| Capital expenditures | 124 | 135 | 120 | 130 | 122 | 122 | 107 | 119 | +1.2% |
| Free cash flow (CFO − capex) | 437 | 205 | 122 | 341 | 438 | 239 | 117 | 206 | −0.2% |
| Depreciation and amortization | 194 | 190 | 185 | 186 | 183 | 177 | 176 | 174 | +6.1% |
| Share repurchases | 92 | 300 | 260 | 500 | 300 | 127 | 0 | 0 | −69.3% |
| Dividends paid | 66 | 66 | 67 | 61 | 62 | 62 | 49 | 48 | +7.2% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 19, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 19, 2026 | FY2024ended Dec 31, 2024filed Feb 20, 2025 | FY2023ended Dec 31, 2023filed Feb 22, 2024 | FY2022ended Dec 31, 2022filed Feb 23, 2023 | FY2021ended Dec 31, 2021filed Feb 24, 2022 | FY2020ended Dec 31, 2020filed Feb 25, 2021 | FY2019ended Dec 31, 2019filed Feb 20, 2020 | FY2018ended Dec 31, 2018filed Feb 21, 2019 | FY2017ended Dec 31, 2017filed Mar 1, 2018 | FY2016ended Dec 31, 2016filed Feb 22, 2017 | FY2015ended Dec 31, 2015filed Feb 24, 2016 | FY2014ended Dec 31, 2014filed Feb 25, 2015 | FY2013ended Dec 31, 2013filed Feb 28, 2014 | FY2012ended Dec 31, 2012filed Feb 22, 2013 | FY2011ended Dec 31, 2011filed Feb 23, 2012 | FY2010ended Dec 31, 2010filed Feb 23, 2011 | FY2009ended Dec 31, 2009filed Apr 29, 2010 | FY2008ended Dec 31, 2008filed Apr 29, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,075 | 5,681 | 5,265 | 5,122 | 4,924 | 4,128 | 3,508 | 3,412 | 3,362 | 3,145 | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 1,614 | 1,451 | 1,386 | 1,329 | 1,325 | 1,323 | 1,990 | 1,213 | 1,032 | 941 | 884 | 752 | 716 | 674 | 560 | 507 | 470 | 491 |
| Operating income | 1,095 | 1,042 | 934 | 1,056 | 1,138 | 677 | (335) | 448 | 832 | 825 | 694 | 638 | 611 | 480 | 469 | 430 | 382 | 439 |
| Other income (expense) | 12 | (2) | 26 | 57 | (43) | 150 | 33 | 26 | 8 | (5) | 7 | 5 | (11) | 7 | (8) | 1 | 6 | 6 |
| Pretax income | 895 | 811 | 718 | 930 | 949 | 685 | (414) | 370 | 747 | 728 | 637 | 574 | 530 | 431 | 406 | 375 | 331 | — |
| Income tax | 231 | 203 | 166 | 230 | 201 | 159 | (36) | 53 | 149 | 233 | 202 | 200 | 189 | 156 | 167 | 132 | 107 | 119 |
| Net income | 660 | 604 | 545 | 696 | 744 | 520 | (384) | 311 | 587 | 489 | 429 | 367 | 352 | 272 | 233 | 267 | 234 | 273 |
| Diluted EPS ($) | 5.32 | 4.84 | 4.40 | 5.65 | 6.02 | 4.24 | (3.15) | 2.56 | 4.83 | 4.04 | 3.55 | 2.97 | 2.84 | 2.22 | 1.88 | 2.11 | 1.83 | 2.09 |
| Diluted shares (millions) | 124 | 125 | 124 | 123 | 124 | 123 | 122 | 121 | 122 | 121 | 121 | 124 | 124 | 123 | 124 | 127 | 128 | 130 |
Balance sheet
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 19, 2026 | FY2024ended Dec 31, 2024filed Feb 20, 2025 | FY2023ended Dec 31, 2023filed Feb 22, 2024 | FY2022ended Dec 31, 2022filed Feb 23, 2023 | FY2021ended Dec 31, 2021filed Feb 24, 2022 | FY2020ended Dec 31, 2020filed Feb 25, 2021 | FY2019ended Dec 31, 2019filed Feb 20, 2020 | FY2018ended Dec 31, 2018filed Feb 21, 2019 | FY2017ended Dec 31, 2017filed Mar 1, 2018 | FY2016ended Dec 31, 2016filed Feb 22, 2017 | FY2015ended Dec 31, 2015filed Feb 24, 2016 | FY2014ended Dec 31, 2014filed Feb 25, 2015 | FY2013ended Dec 31, 2013filed Feb 28, 2014 | FY2012ended Dec 31, 2012filed Feb 22, 2013 | FY2011ended Dec 31, 2011filed Feb 23, 2012 | FY2010ended Dec 31, 2010filed Feb 23, 2011 | FY2009ended Dec 31, 2009filed Apr 29, 2010 | FY2008ended Dec 31, 2008filed Apr 29, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 181 | 170 | 217 | 285 | 225 | 1,685 | 401 | 224 | 336 | 129 | 93 | 128 | 236 | 147 | 128 | 119 | 103 | 58 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current assets | 1,412 | 1,361 | 1,356 | 1,371 | 1,121 | 2,478 | 1,209 | 902 | 998 | 673 | 562 | 591 | 648 | 539 | 457 | 433 | 417 | — |
| Total assets | 11,864 | 11,759 | 12,280 | 11,548 | 11,041 | 9,612 | 7,909 | 7,153 | 7,233 | 6,664 | 4,502 | 4,661 | 4,540 | 4,520 | 3,519 | 3,438 | 3,551 | — |
| Total current liabilities | 2,335 | 1,812 | 2,019 | 2,015 | 2,291 | 2,483 | 1,359 | 827 | 1,674 | 1,260 | 604 | 823 | 663 | 647 | 365 | 320 | 492 | — |
| Long-term debt | 4,055 | 4,323 | 4,748 | 4,820 | 4,470 | 3,277 | 3,380 | 2,631 | 1,739 | 2,087 | 1,138 | 1,146 | 1,146 | 1,447 | 966 | 979 | 991 | — |
| Total liabilities | 7,126 | 6,840 | 7,593 | 7,575 | 7,440 | 6,402 | 5,286 | 3,998 | 3,994 | 3,943 | 2,151 | 2,426 | 2,199 | 2,561 | 1,797 | 1,729 | 1,936 | — |
| Stockholders’ equity | 4,604 | 4,797 | 4,534 | 3,957 | 3,584 | 3,168 | 2,579 | 3,108 | 3,174 | 2,663 | 2,311 | 2,200 | 2,301 | 1,933 | 1,702 | 1,691 | 1,601 | — |
| Shares outstanding (millions) | 120 | 124 | 124 | 122 | 122 | 122 | 121 | 121 | 120 | 120 | 119 | 119 | 122 | 120 | 120 | 123 | 127 | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 19, 2026 | FY2024ended Dec 31, 2024filed Feb 20, 2025 | FY2023ended Dec 31, 2023filed Feb 22, 2024 | FY2022ended Dec 31, 2022filed Feb 23, 2023 | FY2021ended Dec 31, 2021filed Feb 24, 2022 | FY2020ended Dec 31, 2020filed Feb 25, 2021 | FY2019ended Dec 31, 2019filed Feb 20, 2020 | FY2018ended Dec 31, 2018filed Feb 21, 2019 | FY2017ended Dec 31, 2017filed Mar 1, 2018 | FY2016ended Dec 31, 2016filed Feb 22, 2017 | FY2015ended Dec 31, 2015filed Feb 24, 2016 | FY2014ended Dec 31, 2014filed Feb 25, 2015 | FY2013ended Dec 31, 2013filed Feb 28, 2014 | FY2012ended Dec 31, 2012filed Feb 22, 2013 | FY2011ended Dec 31, 2011filed Feb 23, 2012 | FY2010ended Dec 31, 2010filed Feb 23, 2011 | FY2009ended Dec 31, 2009filed Apr 29, 2010 | FY2008ended Dec 31, 2008filed Apr 29, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,616 | 1,325 | 1,117 | 757 | 1,335 | 946 | 314 | 672 | 816 | 823 | 769 | 616 | 569 | 496 | 409 | 353 | 418 | 448 |
| Capital expenditures | 481 | 512 | 601 | 625 | 469 | 421 | 400 | 322 | 218 | 174 | 146 | 86 | 83 | 66 | 75 | 100 | 71 | 111 |
| Free cash flow (CFO − capex) | 1,134 | 813 | 516 | 133 | 866 | 525 | (86) | 350 | 598 | 650 | 623 | 530 | 486 | 430 | 334 | 253 | 348 | 338 |
| Depreciation and amortization | 727 | 681 | 620 | 569 | 490 | 399 | 337 | 316 | 291 | 269 | 200 | 204 | 190 | 163 | 165 | 168 | 159 | 155 |
| Share repurchases | 928 | 0 | 0 | 0 | 70 | 0 | 0 | 0 | 77 | 0 | 196 | 302 | 12 | 85 | 142 | 168 | 24 | 156 |
| Dividends paid | 233 | 193 | 192 | 191 | 190 | 190 | 189 | 188 | 187 | 158 | 138 | 121 | 107 | 86 | 78 | 35 | 20 | 21 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | Begor Mark W | CEO, Director | option exercise | 37,792 | $112.46 | $4M | 327,714 | Oct 27, 2026 |
| Oct 23, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 1,194 | $186.73 | $223K | 326,520 | Oct 27, 2026 |
| Oct 23, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 1,250 | $183.40 | $229K | 325,270 | Oct 27, 2026 |
| Oct 23, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 1,681 | $185.20 | $311K | 323,589 | Oct 27, 2026 |
| Oct 23, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 33,667 | $182.52 | $6M | 289,922 | Oct 27, 2026 |
| Sep 3, 2026 | Gamble John W JR | EVP, CFO & COO | open-market sale10b5-1 | 4,500 | $187.96 | $846K | 69,055 | Sep 8, 2026 |
| Jul 24, 2026 | Begor Mark W | CEO, Director | option exercise | 37,791 | $112.46 | $4M | 309,681 | Jul 28, 2026 |
| Jul 24, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 500 | $175.85 | $88K | 309,181 | Jul 28, 2026 |
| Jul 24, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 600 | $169.86 | $102K | 308,581 | Jul 28, 2026 |
| Jul 24, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 600 | $168.47 | $101K | 307,981 | Jul 28, 2026 |
| Jul 24, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 1,300 | $174.91 | $227K | 306,681 | Jul 28, 2026 |
| Jul 24, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 2,936 | $173.79 | $510K | 303,745 | Jul 28, 2026 |
| Jul 24, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 4,112 | $172.79 | $711K | 299,633 | Jul 28, 2026 |
| Jul 24, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 6,200 | $171.26 | $1M | 293,433 | Jul 28, 2026 |
| Jul 24, 2026 | Begor Mark W | CEO, Director | open-market sale10b5-1 | 21,543 | $172.00 | $4M | 271,890 | Jul 28, 2026 |
| May 7, 2026 | Tillman Audrey B | Director | award | 1,253 | $175.62 | $220K | 6,677 | May 11, 2026 |
| May 7, 2026 | Smith Melissa D | Director | award | 1,253 | $175.62 | $220K | 6,802 | May 11, 2026 |
| May 7, 2026 | McKinley John A | Director | award | 1,253 | $175.62 | $220K | 34,717 | May 11, 2026 |
| May 7, 2026 | Mcgregor Scott A | Director | award | 1,253 | $175.62 | $220K | 11,308 | May 11, 2026 |
| May 7, 2026 | Marcus Robert D | Director | award | 1,253 | $175.62 | $220K | 18,349 | May 11, 2026 |
| May 7, 2026 | Larson Barbara A | Director | award | 1,253 | $175.62 | $220K | 3,877 | May 11, 2026 |
| May 7, 2026 | Hough G. Thomas | Director | award | 1,253 | $175.62 | $220K | 16,309 | May 11, 2026 |
| May 7, 2026 | Fichuk Karen L | Director | award | 1,253 | $175.62 | $220K | 4,993 | May 11, 2026 |
| May 7, 2026 | Feidler Mark L | Director | award | 1,253 | $175.62 | $220K | 25,077 | May 11, 2026 |
| May 7, 2026 | Borton Chad M | EVP, Pres Workforce Solutions | open-market sale10b5-1 | 2,455 | $173.89 | $427K | 29,518 | May 8, 2026 |
Full insider history for Equifax, Incorporated, or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held EFX in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded EFX by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Baron Capital Group | Ron Baron | Q2 2026 | $423K | 2,668 | 0.00% | trimmed −1.3% |
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- EQUIFAX INC, CIK 33185 on EDGAR
- Extract generated
- November 1, 2026
- Withheld
- 6 line-years whose four quarters do not sum to the filed year: depreciation amortization FY2009, income tax FY2009, operating income FY2009, other income FY2009, depreciation amortization FY2010, depreciation amortization FY2018
- Repaired
- none
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTaxSellingGeneralAndAdministrativeExpenseOperatingIncomeLossOtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAssetsCurrentAssetsLiabilitiesCurrentLongTermDebtNoncurrentLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquireProductiveAssetsDepreciationAndAmortization, DepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsCommonStockThe data
The statements on this page as files, generated November 1, 2026.
- JSON file
/data/financials/EFX.json